An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children

BMC Public Health

Volumn 11, Issue SUPPL. 3, 2011, Pages

  Huda, Tanvir ^a   Nair, Harish ^b,c   Theodoratou, Evropi ^b   Zgaga, Lina ^b   Fattom, Ali ^d   El Arifeen, Shams ^a   Rubens, Craig ^e   Campbell, Harry ^b   Rudan, Igor ^b,f  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^d Nabi Biopharmaceuticals   (United States)

^e Global Alliance to Prevent Prematurity and Stillbirth   (United States)

^f UNIVERSITY OF SPLIT   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

STAPHYLOCOCCUS VACCINE;

CHILD; EVALUATION; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

CHILD; HUMANS; IMMUNOTHERAPY; PNEUMONIA, STAPHYLOCOCCAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 79954467412     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-S3-S27     Document Type: Article

References (61)

1. Global, regional, and national causes of child mortality in 2008: a systematic analysis. RE Black S Cousens HL Johnson JE Lawn I Rudan DG Bassani P Jha H Campbell CF Walker R Cibulskis T Eisele L Liu C Mathers, Lancet 2010 375 9730 1969 1987 10.1016/S0140-6736(10)60549-1 20466419
2. Staphylococcus aureus infections. FD Lowy, N Engl J Med 1998 339 8 520 532 10.1056/NEJM199808203390806 9709046
3. The prospects for developing a vaccine against Staphylococcus aureus. JC Lee, Trends Microbiol 1996 4 4 162 166 10.1016/0966-842X(96)10021-4 8728611 (Pubitemid 26133325)
4. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. MD Sanford AF Widmer MJ Bale RN Jones RP Wenzel, Clin Infect Dis 1994 19 6 1123 1128 10.1093/clinids/19.6.1123 7888543 (Pubitemid 24380028)
5. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 2002 30 8 458 475 10.1067/mic.2002.130032 12461510
6. Pneumonia caused by methicillin-resistant Staphylococcus aureus. E Rubinstein MH Kollef D Nathwani, Clin Infect Dis 2008 46 Suppl 5 378 385 10.1086/533594 18462093
7. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. MH Kollef LE Morrow MS Niederman KV Leeper A Anzueto L Benz-Scott FJ Rodino, Chest 2006 129 5 1210 1218 10.1378/chest.129.5. 1210 16685011
8. Staphylococcal vaccines and immunotherapies. AC Schaffer JC Lee, Infect Dis Clin North Am 2009 23 1 153 171 10.1016/j.idc.2008.10.005 19135920
9. Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus. RD Arbeit WW Karakawa WF Vann JB Robbins, Diagn Microbiol Infect Dis 1984 2 2 85 91 10.1016/0732-8893(84)90002-6 6232086 (Pubitemid 15188048)
10. Intermediate vancomycin susceptibility in a community-associated MRSA clone. CJ Graber MK Wong HA Carleton F Perdreau-Remington BL Haller HF Chambers, Emerg Infect Dis 2007 13 3 491 493 10.3201/eid1303.060960 17552110 (Pubitemid 46348141)
11. Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. W Zhu NC Clark LK McDougal J Hageman LC McDonald JB Patel, Antimicrob Agents Chemother 2008 52 2 452 457 10.1128/AAC.00908-07 18056272 (Pubitemid 351170813)
12. Setting priorities in global child health research investments: addressing values of stakeholders. L Kapiriri M Tomlinson M Chopra S El Arifeen RE Black I Rudan, Croat Med J 2007 48 5 618 627 17948948 (Pubitemid 350022002)
13. The complex challenge of setting priorities in health research investments. I Rudan, Indian J Med Res 2009 129 4 351 353 19535827
14. Setting priorities in global child health research investments: universal challenges and conceptual framework. I Rudan M Chopra L Kapiriri J Gibson M Ann Lansang I Carneiro S Ameratunga AC Tsai KY Chan M Tomlinson SY Hess H Campbell S El Arifeen RE Black, Croat Med J 2008 49 3 307 317 10.3325/cmj.2008.3.307 18581609 (Pubitemid 351955763)
15. Childhood pneumonia and diarrhoea: setting our priorities right. I Rudan S El Arifeen RE Black H Campbell, Lancet Infect Dis 2007 7 1 56 61 10.1016/S1473-3099(06)70687-9 17182344 (Pubitemid 44917782)
16. Setting priorities in global child health research investments: assessment of principles and practice. I Rudan J Gibson L Kapiriri MA Lansang AA Hyder J Lawn GL Darmstadt S Cousens ZA Bhutta KH Brown SY Hess M Black JM Gardner J Webster I Carneiro D Chandramohan M Kosek CF Lanata M Tomlinson M Chopra S Ameratunga H Campbell S El Arifeen RE Black, Croat Med J 2007 48 5 595 604 17948946 (Pubitemid 350022000)
17. Research priorities to reduce global mortality from newborn infections by 2015. R Bahl J Martines N Ali MK Bhan W Carlo KY Chan GL Darmstadt DH Hamer JE Lawn DD McMillan P Mohan V Paul AC Tsai CG Victora MW Weber AK Zaidi I Rudan, Pediatr Infect Dis J 2009 28 1 Suppl 43 48 19106763
18. Setting research priorities to reduce global mortality from childhood diarrhoea by 2015. O Fontaine M Kosek S Bhatnagar C Boschi-Pinto KY Chan C Duggan H Martinez H Ribeiro NC Rollins MA Salam M Santosham JD Snyder AC Tsai B Vargas I Rudan, PLoS Med 2009 6 3 41 10.1371/journal.pmed.1000041 19278292
19. Setting priorities in global child health research investments: guidelines for implementation of CHNRI method. I Rudan JL Gibson S Ameratunga S El Arifeen ZA Bhutta M Black RE Black KH Brown H Campbell I Carneiro KY Chan D Chandramohan M Chopra S Cousens GL Darmstadt J Meeks Gardner SY Hess AA Hyder L Kapiriri M Kosek CF Lanata MA Lansang J Lawn M Tomlinson AC Tsai J Webster, Croat Med J 2008 49 6 720 733 10.3325/cmj.2008.49.720 19090596
20. Setting priorities in child health research investments for South Africa. M Tomlinson M Chopra D Sanders D Bradshaw M Hendricks D Greenfield RE Black S El Arifeen I Rudan, PLoS Med 2007 4 8 259 10.1371/journal.pmed.0040259 17760497
21. Setting priorities for global mental health research. M Tomlinson I Rudan S Saxena L Swartz AC Tsai V Patel, Bull World Health Organ 2009 87 6 438 446 10.2471/BLT.08.054353 19565122
22. Research priorities for health of people with disabilities: an expert opinion exercise. M Tomlinson L Swartz A Officer KY Chan I Rudan S Saxena, Lancet 2009 374 9704 1857 1862 10.1016/S0140-6736(09)61910-3 19944866
23. Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus. W Karakawa J Fournier W Vann R Arbeit R Schneerson J Robbins, J Clin Microbiol 1985 22 445 447 3930565 (Pubitemid 15018586)
24. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. W Karakawa A Sutton R Schneerson A Karpas W Vann, Infect Immun 1988 56 1090 1095 3356460
25. Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8. HK Hochkeppel DG Braun W Vischer A Imm S Sutter U Staeubli R Guggenheim EL Kaplan A Boutonnier JM Fournier, J Clin Microbiol 1987 25 3 526 530 2437148 (Pubitemid 17015564)
26. Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types. D Sompolinsky Z Samra WW Karakawa WF Vann R Schneerson Z Malik, J Clin Microbiol 1985 22 5 828 834 2932464 (Pubitemid 16217795)
27. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. A Fattom R Schneerson SC Szu WF Vann J Shiloach WW Karakawa JB Robbins, Infect Immun 1990 58 7 2367 2374 2114365 (Pubitemid 20212320)
28. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. NA Kuklin DJ Clark S Secore J Cook LD Cope T McNeely L Noble MJ Brown JK Zorman XM Wang G Pancari H Fan K Isett B Burgess J Bryan M Brownlow H George M Meinz ME Liddell R Kelly L Schultz D Montgomery J Onishi M Losada M Martin T Ebert CY Tan TL Schofield E Nagy A Meineke,, et al. Infect Immun 2006 74 4 2215 2223 10.1128/IAI.74.4.2215-2223.2006 16552052
29. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. H Etz DB Minh T Henics A Dryla B Winkler C Triska AP Boyd J Sollner W Schmidt U von Ahsen M Buschle SR Gill J Kolonay H Khalak CM Fraser A von Gabain E Nagy A Meinke, Proc Natl Acad Sci U S A 2002 99 10 6573 6578 10.1073/pnas.092569199 11997460 (Pubitemid 34526174)
30. Surface protein adhesins of Staphylococcus aureus. TJ Foster M Hook, Trends Microbiol 1998 6 12 484 488 10.1016/S0966-842X(98)01400-0 10036727 (Pubitemid 29002881)
31. Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis. J Vernachio AS Bayer T Le YL Chai B Prater A Schneider B Ames P Syribeys J Robbins JM Patti, Antimicrob Agents Chemother 2003 47 11 3400 3406 10.1128/AAC.47.11.3400-3406.2003 14576094 (Pubitemid 37345696)
32. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). R Asghar S Banajeh J Egas P Hibberd I Iqbal M Katep-Bwalya Z Kundi P Law W MacLeod I Maulen-Radovan G Mino S Saha F Sempertegui J Simon M Santosham S Singhi DM Thea S Qazi, Bmj 2008 336 7635 80 84 10.1136/bmj.39421.435949.BE 18182412
33. Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. JJ Weems Jr. JP Steinberg S Filler JW Baddley GR Corey P Sampathkumar L Winston JF John CJ Kubin R Talwani T Moore JM Patti S Hetherington M Texter E Wenzel VA Kelley VG Fowler Jr., Antimicrob Agents Chemother 2006 50 8 2751 2755 10.1128/AAC.00096-06 16870768 (Pubitemid 44198697)
34. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. BJ Stoll N Hansen AA Fanaroff LL Wright WA Carlo RA Ehrenkranz JA Lemons EF Donovan AR Stark JE Tyson W Oh CR Bauer SB Korones S Shankaran AR Laptook DK Stevenson LA Papile WK Poole, Pediatrics 2002 110 2 Pt 1 285 291 10.1542/peds.110.2.285 12165580 (Pubitemid 34833012)
35. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. H Shinefield S Black A Fattom G Horwith S Rasgon J Ordonez H Yeoh D Law JB Robbins R Schneerson L Muenz S Fuller J Johnson B Fireman H Alcorn R Naso, N Engl J Med 2002 346 7 491 496 10.1056/NEJMoa011297 11844850 (Pubitemid 34441740)
36. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. G Lina Y Piemont F Godail-Gamot M Bes MO Peter V Gauduchon F Vandenesch J Etienne, Clin Infect Dis 1999 29 5 1128 1132 10.1086/313461 10524952 (Pubitemid 30265628)
37. Virulence determinants in community and hospital meticillin-resistant Staphylococcus aureus. A Tristan T Ferry G Durand O Dauwalder M Bes G Lina F Vandenesch J Etienne, J Hosp Infect 2007 65 Suppl 2 105 109 10.1016/S0195- 6701(07)60025-5 17540252 (Pubitemid 46805847)
38. Two phase I, multicenter, double-blind studies to investigate immunogenicity and safety of different formulations of a novel Staphylococcus aureus (SA) vaccine (V710). C Harro R Betts J Lipka J Hartzel M Onorato Nicholas Kartsonis, International Symposium on Staphylococci and Staphylococcal Infections Cairns, Australia 2008
39. Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants. B Bloom R Schelonka T Kueser W Walker E Jung D Kaufman K Kesler D Roberson J Patti S Hetherington, Pediatr Infect Dis J 2005 24 10 858 866 10.1097/01.inf.0000180504.66437.1f 16220082 (Pubitemid 41475919)
40. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. M DeJonge D Burchfield B Bloom M Duenas W Walker M Polak E Jung D Millard R Schelonka F Eyal A Morris B Kapik D Roberson K Kesler J Patti S Hetherington, J Pediatr 2007 151 3 260-265 265 e261 17719934
41. A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin. DK Benjamin R Schelonka R White HP Holley E Bifano J Cummings K Adcock D Kaufman B Puppala P Riedel B Hall J White CM Cotton, J Perinatol 2006 26 5 290 295 10.1038/sj.jp.7211496 16598296
42. Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia. ME Rupp HP Holley Jr. J Lutz PV Dicpinigaitis CW Woods DP Levine N Veney VG Fowler Jr., Antimicrob Agents Chemother 2007 51 12 4249 4254 10.1128/AAC.00570-07 17893153 (Pubitemid 350209873)
43. Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates. LE Weisman HM Thackray JA Garcia-Prats M Nesin JH Schneider J Fretz JF Kokai-Kun JJ Mond WG Kramer GW Fischer, Antimicrob Agents Chemother 2009 53 7 2879 2886 10.1128/AAC.01565-08 19380597
44. Antibody for the prevention of neonatal noscocomial staphylococcal infection: a review of the literature. LE Weisman, Arch Pediatr 2007 14 Suppl 1 31 S34 10.1016/S0929-693X(07)80008-X 17939955
45. Global estimate of the incidence of clinical pneumonia among children under five years of age. I Rudan L Tomaskovic C Boschi-Pinto H Campbell, Bull World Health Organ 2004 82 12 895 903 15654403 (Pubitemid 40065157)
46. The etiology of pneumonia in malnourished and well-nourished Gambian children. RA Adegbola AG Falade BE Sam M Aidoo I Baldeh D Hazlett H Whittle BM Greenwood EK Mulholland, Pediatr Infect Dis J 1994 13 11 975 982 10.1097/00006454-199411000-00008 7845751 (Pubitemid 24363107)
47. Bacterial isolates from blood and lung aspirate cultures in Gambian children with lobar pneumonia. AG Falade EK Mulholland RA Adegbola BM Greenwood, Ann Trop Paediatr 1997 17 4 315 319 9578790 (Pubitemid 27511113)
48. Etiology of acute lower respiratory tract infections in Gambian children: I. Acute lower respiratory tract infections in infants presenting at the hospital. IM Forgie KP O'Neill N Lloyd-Evans M Leinonen H Campbell HC Whittle BM Greenwood, Pediatr Infect Dis J 1991 10 1 33 41 10.1097/00006454-199101000- 00008 1848364
49. Etiology of acute lower respiratory tract infections in Gambian children: II. Acute lower respiratory tract infection in children ages one to nine years presenting at the hospital. IM Forgie KP O'Neill N Lloyd-Evans M Leinonen H Campbell HC Whittle BM Greenwood, Pediatr Infect Dis J 1991 10 1 42 47 10.1097/00006454-199101000-00009 2003054
50. Pneumocystis carinii pneumonia in Africa. Y Kamiya E Mtitimila R Broadhead B Brabin CA Hart, Lancet 1996 347 9008 1114 1115 10.1016/S0140- 6736(96)90311-6 8602081
51. Pneumocystis carinii pneumonia in Malawian children. Y Kamiya E Mtitimila SM Graham RL Broadhead B Brabin CA Hart, Ann Trop Paediatr 1997 17 2 121 126 9230974 (Pubitemid 27289363)
52. Etiology of severe pneumonia in children in developing countries. F Shann, Pediatr Infect Dis 1986 5 2 247 252 10.1097/00006454-198603000-00017 3952013 (Pubitemid 16162869)
53. Determining etiology of pneumonia. F Shann, Pediatr Infect Dis J 1995 14 10 920 921 8584332
54. Lung puncture in the etiological diagnosis of pneumonia. A study of 543 infants and children. I Mimica E Donoso JE Howard GW Ledermann, Am J Dis Child 1971 122 4 278 282 4398908
55. Ventilator-associated pneumonia. J Chastre JY Fagon, Am J Respir Crit Care Med 2002 165 7 867 903 11934711 (Pubitemid 34774654)
56. Nosocomial infections in combined medical-surgical intensive care units in the United States. MJ Richards JR Edwards DH Culver RP Gaynes, Infect Control Hosp Epidemiol 2000 21 8 510 515 10.1086/501795 10968716 (Pubitemid 30647154)
57. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. HA Carleton BA Diep ED Charlebois GF Sensabaugh F Perdreau-Remington, J Infect Dis 2004 190 10 1730 1738 10.1086/425019 15499526 (Pubitemid 39487815)
58. Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The WHO Young Infants Study Group. Pediatr Infect Dis J 1999 18 10 Suppl 17 22 10530569
59. Cold chain, WHO African Region: Ethiopia. http://www.who.int/countries/ eth/areas/immunization/epi-logistics/en/index1.html
60. Staphylococcal vaccines and immunotherapy: to dream the impossible dream? SJ Projan M Nesin PM Dunman, Curr Opin Pharmacol 2006 6 5 473 479 10.1016/j.coph.2006.04.005 16870507 (Pubitemid 44362069)
61. Staphylococcal innate immune evasion. SH Rooijakkers KP van Kessel JA van Strijp, Trends Microbiol 2005 13 12 596 601 10.1016/j.tim.2005.10.002 16242332 (Pubitemid 41661341)